Brand-name weekly injectables (Wegovy semaglutide, Zepbound tirzepatide) typically list between about $1,000 and $1,400 per 28-day supply when paid out of pocket, depending on dose and pharmacy
In other cases, it may be a minor increase in heart rate
Always consult your healthcare provider before making any changes to your medication regimen
Authentic Novo Nordisk T2D Indication Authentic Ozempic from Novo Nordisk the original semaglutide, approved for type-2 diabetes the brand that started GLP-1 weight loss Same molecule as Wegovy (FDA-approved for chronic weight management)
Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease